Valeant Pharmaceuticals Intl I - VRX - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Valeant Pharmaceuticals Intl I - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
VRX	New York	2834	http://www.valeant.com	74.10 -0.57
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Valeant Pharmaceuticals Intl I Favorable Verdict for Mylan - May 22nd, 2013 4:10 pm A first in Quebec: Valeant officially inaugurates its international headquarters in Laval - May 21st, 2013 5:03 pm Valeant Pharmaceuticals Announces 2013 Annual Meeting Results - May 21st, 2013 3:01 pm Valeant Pharmaceuticals Announces 2013 Annual Meeting Results - May 21st, 2013 3:00 pm A Good Deal For Actavis, But Warner Chilcott Goes A Little Cheap - May 21st, 2013 12:00 pm Actavis: The latest Fortune 500 company to "leave" the U.S. for tax reasons - May 21st, 2013 9:23 am VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders - May 21st, 2013 8:10 am Actavis buying Warner Chilcott in $8.5B deal - May 20th, 2013 4:36 pm Actavis buying Warner Chilcott in $8.5B deal - May 20th, 2013 4:36 pm Everyone Wins From This Acquisition - May 20th, 2013 4:32 pm Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference - May 20th, 2013 3:01 pm Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference - May 20th, 2013 3:00 pm [$$] Actavis Prepares for Its Next Act - May 20th, 2013 11:50 am Actavis to buy Warner Chilcott in $5 billion stock deal - May 20th, 2013 8:46 am [video] Faber Report: Actavis to Buy Warner Chilcott - May 20th, 2013 7:15 am Actavis to Buy Warner Chilcott in All-Stock Deal - May 20th, 2013 6:03 am Early Movers: YHOO, CPB, BA, GE & More - May 20th, 2013 6:00 am Actavis to buy Warner Chilcott in $8.5 billion stock deal - May 20th, 2013 5:51 am Actavis to Buy Warner Chilcott in $5B Stock Deal - May 20th, 2013 5:23 am 5 Stocks Mega-Fund Osterweis Capital Is Bullish On - May 17th, 2013 11:54 am View All Current Headlines >>